Literature DB >> 15625030

Treatment of Giardiasis.

William A Petri1.   

Abstract

Tinidazole is the first-line drug treatment of giardiasis, as it requires only a single dose to cure infection in most individuals. The related drug metronidazole is as effective, but it requires 5 to 7 days of three times a day therapy. Nitazoxanide appears in limited studies to be as effective as tinidazole or metronidazole, and it does not have the bitter taste of nitroimidazoles. A good alternate for use during pregnancy is paromomycin. Cure of infection varies between 60% and 100% with one course of treatment. Less effective and/or less well-tolerated drugs for the treatment of giardiasis include albendazole, quinacrine, and furazolidone; the use of these agents should be reserved for giardiasis refractory to treatment with the first-line agents.

Entities:  

Year:  2005        PMID: 15625030     DOI: 10.1007/s11938-005-0047-3

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  14 in total

Review 1.  Treatment of Giardia lamblia infections.

Authors:  T E Nash
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

Review 2.  Surface antigenic variation in Giardia lamblia.

Authors:  Theodore E Nash
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

3.  Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide.

Authors:  J F Rossignol; A Ayoub; M S Ayers
Journal:  J Infect Dis       Date:  2001-07-10       Impact factor: 5.226

4.  Water disinfection in the wilderness--a simple, effective method of iodination.

Authors:  F H Kahn; B R Visscher
Journal:  West J Med       Date:  1975-05

5.  Epidemiological and molecular evidence supports the zoonotic transmission of Giardia among humans and dogs living in the same community.

Authors:  R J Traub; P T Monis; I Robertson; P Irwin; N Mencke; R C A Thompson
Journal:  Parasitology       Date:  2004-03       Impact factor: 3.234

6.  Age and sex distribution of infections with Entamoeba histolytica and Giardia intestinalis in the Lagos population.

Authors:  J P Oyerinde; O Ogunbi; A A Alonge
Journal:  Int J Epidemiol       Date:  1977-09       Impact factor: 7.196

7.  Occurrence of Giardia lamblia in children in day care centers.

Authors:  L K Pickering; W E Woodward; H L DuPont; P Sullivan
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

Review 8.  Nitazoxanide treatment for giardiasis and cryptosporidiosis in children.

Authors:  Jason M Bailey; John Erramouspe
Journal:  Ann Pharmacother       Date:  2004-02-27       Impact factor: 3.154

9.  Epidemiology of diarrhea among expatriate residents living in a highly endemic environment.

Authors:  C W Hoge; D R Shlim; P Echeverria; R Rajah; J E Herrmann; J H Cross
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

10.  Acute giardiasis: an improved clinical case definition for epidemiologic studies.

Authors:  R S Hopkins; D D Juranek
Journal:  Am J Epidemiol       Date:  1991-02-15       Impact factor: 4.897

View more
  11 in total

1.  Short course combination therapy for giardiasis after nitroimidazole failure.

Authors:  Rogelio Lopez-Velez; Carolina Batlle; Carolina Jiménez; Miriam Navarro; Francesca Norman; Jose Perez-Molina
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  Single and Synergistic Effects of Fenbendazole and Metronidazole Against Subclinical Infection by Giardia duodenalis in Non-Human Primates in a Zoological Garden in Southern Italy.

Authors:  Michele Capasso; Lavinia Ciuca; Isabel Guadano Procesi; Francesco Zinno; Federica Berrilli; Giuseppe Cringoli; Laura Rinaldi
Journal:  Front Vet Sci       Date:  2022-06-16

3.  Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole.

Authors:  Joshua A Kramer; Audra M Hachey; Lynn M Wachtman; Keith G Mansfield
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

4.  Terminal restriction fragment length polymorphism for identification of Cryptosporidium species in human feces.

Authors:  L S Waldron; B C Ferrari; M R Gillings; M L Power
Journal:  Appl Environ Microbiol       Date:  2008-10-31       Impact factor: 4.792

5.  Preventive role of probiotic bacteria against gastrointestinal diseases in mice caused by Giardia lamblia.

Authors:  Wafa A Al-Megrin; Shadia H Mohamed; Moudy M Saleh; Hany M Yehia
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.976

6.  Extracellular vesicles secreted by Giardia duodenalis regulate host cell innate immunity via TLR2 and NLRP3 inflammasome signaling pathways.

Authors:  Panpan Zhao; Lili Cao; Xiaocen Wang; Jingquan Dong; Nan Zhang; Xin Li; Jianhua Li; Xichen Zhang; Pengtao Gong
Journal:  PLoS Negl Trop Dis       Date:  2021-04-02

7.  Survey of obstetrician-gynecologists about giardiasis.

Authors:  Amy Krueger; Jay Schulkin; Jeffrey L Jones
Journal:  Infect Dis Obstet Gynecol       Date:  2007

8.  Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region.

Authors:  Gloria Hernández-Alcántara; Alfredo Torres-Larios; Sergio Enríquez-Flores; Itzhel García-Torres; Adriana Castillo-Villanueva; Sara T Méndez; Ignacio de la Mora-de la Mora; Saúl Gómez-Manzo; Angélica Torres-Arroyo; Gabriel López-Velázquez; Horacio Reyes-Vivas; Jesús Oria-Hernández
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

9.  Antigiardial Effect of Kramecyne in Experimental Giardiasis.

Authors:  Leticia Eligio-García; Elida Pontifez-Pablo; Salúd Pérez-Gutiérrez; Enedina Jiménez-Cardoso
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-13       Impact factor: 2.629

10.  Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo.

Authors:  Thibault Allain; Soraya Chaouch; Myriam Thomas; Isabelle Vallée; André G Buret; Philippe Langella; Philippe Grellier; Bruno Polack; Luis G Bermúdez-Humarán; Isabelle Florent
Journal:  Front Microbiol       Date:  2018-01-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.